Biology and Management of Multiple Myeloma (Current Clinical Oncology)
Published: Oct 15, 2008 8:00 am
|
Editor: James R. Berenson Book Description: Expert physicians and clinical researchers summarize and explain all the recent advances in the biology and treatment of bone marrow-based malignancy. On the biological side, the authors show the characteristics of the malignant cell and describe the significant roles played by oncogenic changes, chromosomal anomalies, Kaposi's sarcoma herpes virus, and cytokines. New epidemiological findings and prognostic factors are also analyzed. On the clinical side, the authors provide a comprehensive review of conventional treatment regimens, as well as a discussion of newer experimental approaches involving immunologic targeting, inhibitors of drug resistance, and antitumor agents. |
Related Articles:
- Importance Of Factors Affecting Multiple Myeloma Survival Changes With Patient Age
- Early Use Of Radiation Therapy Associated With Shorter Survival In Multiple Myeloma
- Latest Myeloma Research To Be Presented At The American Society Of Clinical Oncology Annual Meeting (ASCO 2018)
- Researchers Shed More Light On Risk Of MGUS In Close Relatives Of People With Multiple Myeloma
- Darzalex May Affect Different Uninvolved Immunoglobulins Differently
